126 related articles for article (PubMed ID: 38161125)
1. Liver fibrosis, NT-ProBNP and mortality in patients with MASLD: A population-based cohort study.
Ciardullo S; Cannistraci R; Muraca E; Zerbini F; Perseghin G
Nutr Metab Cardiovasc Dis; 2024 Apr; 34(4):963-971. PubMed ID: 38161125
[TBL] [Abstract][Full Text] [Related]
2. NT-ProBNP and mortality across the spectrum of glucose tolerance in the general US population.
Ciardullo S; Rea F; Cannistraci R; Muraca E; Perra S; Zerbini F; Mortara A; Perseghin G
Cardiovasc Diabetol; 2022 Nov; 21(1):236. PubMed ID: 36344968
[TBL] [Abstract][Full Text] [Related]
3. NT-proBNP and All-Cause and Cardiovascular Mortality in US Adults: A Prospective Cohort Study.
Echouffo-Tcheugui JB; Zhang S; Daya N; McEvoy JW; Tang O; Juraschek SP; Ndumele CE; Coresh J; Christenson RH; Selvin E
J Am Heart Assoc; 2023 Jun; 12(11):e029110. PubMed ID: 37232235
[TBL] [Abstract][Full Text] [Related]
4. Obesity and Serial NT-proBNP Levels in Guided Medical Therapy for Heart Failure With Reduced Ejection Fraction: Insights From the GUIDE-IT Trial.
Parcha V; Patel N; Kalra R; Suri SS; Arora G; Wang TJ; Arora P
J Am Heart Assoc; 2021 Apr; 10(7):e018689. PubMed ID: 33754794
[TBL] [Abstract][Full Text] [Related]
5. Association of copeptin and N-terminal proBNP concentrations with risk of cardiovascular death in older patients with symptoms of heart failure.
Alehagen U; Dahlström U; Rehfeld JF; Goetze JP
JAMA; 2011 May; 305(20):2088-95. PubMed ID: 21610241
[TBL] [Abstract][Full Text] [Related]
6. N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults.
Kistorp C; Raymond I; Pedersen F; Gustafsson F; Faber J; Hildebrandt P
JAMA; 2005 Apr; 293(13):1609-16. PubMed ID: 15811980
[TBL] [Abstract][Full Text] [Related]
7. Minimally elevated cardiac troponin T and elevated N-terminal pro-B-type natriuretic peptide predict mortality in older adults: results from the Rancho Bernardo Study.
Daniels LB; Laughlin GA; Clopton P; Maisel AS; Barrett-Connor E
J Am Coll Cardiol; 2008 Aug; 52(6):450-9. PubMed ID: 18672166
[TBL] [Abstract][Full Text] [Related]
8. Dynamic cardiovascular risk assessment in elderly people. The role of repeated N-terminal pro-B-type natriuretic peptide testing.
deFilippi CR; Christenson RH; Gottdiener JS; Kop WJ; Seliger SL
J Am Coll Cardiol; 2010 Feb; 55(5):441-50. PubMed ID: 20117457
[TBL] [Abstract][Full Text] [Related]
9. Associations of N-terminal pro-B-type natriuretic peptide, estimated glomerular filtration rate, and mortality in US adults.
Ozkan B; Grams ME; Coresh J; McEvoy JW; Echouffo-Tcheugui JB; Mu SZ; Tang O; Daya NR; Kim H; Christenson RH; Ndumele CE; Selvin E
Am Heart J; 2023 Oct; 264():49-58. PubMed ID: 37290699
[TBL] [Abstract][Full Text] [Related]
10. Urinary N-terminal pro-B-type natriuretic peptide as a biomarker for cardiovascular events in a general Japanese population: the Hisayama Study.
Yamasaki K; Hata J; Ide T; Nagata T; Sakata S; Yoshida D; Honda T; Hirakawa Y; Nakano T; Kitazono T; Tsutsui H; Ninomiya T
Environ Health Prev Med; 2021 Apr; 26(1):47. PubMed ID: 33845756
[TBL] [Abstract][Full Text] [Related]
11. Predictive value of depressive symptoms and B-type natriuretic peptide for new-onset heart failure and mortality.
van den Broek KC; Defilippi CR; Christenson RH; Seliger SL; Gottdiener JS; Kop WJ
Am J Cardiol; 2011 Mar; 107(5):723-9. PubMed ID: 21316507
[TBL] [Abstract][Full Text] [Related]
12. Association between dietary inflammatory index and NT-proBNP levels in US adults: A cross-sectional analysis.
Ma TC; Gao F; Liu XL; Wang CX; Liu Q; Zhou J
PLoS One; 2024; 19(6):e0304289. PubMed ID: 38837950
[TBL] [Abstract][Full Text] [Related]
13. N-terminal fragment of the prohormone brain-type natriuretic peptide (NT-proBNP), cardiovascular events, and mortality in patients with stable coronary heart disease.
Bibbins-Domingo K; Gupta R; Na B; Wu AH; Schiller NB; Whooley MA
JAMA; 2007 Jan; 297(2):169-76. PubMed ID: 17213400
[TBL] [Abstract][Full Text] [Related]
14. Associations of Cardiac Biomarkers With Peripheral Artery Disease and Peripheral Neuropathy in US Adults Without Prevalent Cardiovascular Disease.
Hicks CW; Wang D; McDermott K; Matsushita K; Tang O; Echouffo-Tcheugui JB; McEvoy JW; Christenson RH; Selvin E
Arterioscler Thromb Vasc Biol; 2023 Aug; 43(8):1583-1591. PubMed ID: 37317848
[TBL] [Abstract][Full Text] [Related]
15. Subclinical Cardiovascular Disease in US Adults With and Without Diabetes.
Fang M; Wang D; Tang O; McEvoy JW; Echouffo-Tcheugui JB; Christenson RH; Selvin E
J Am Heart Assoc; 2023 Jun; 12(11):e029083. PubMed ID: 37254959
[TBL] [Abstract][Full Text] [Related]
16. [Prognostic value of N-terminal B-type natriuretic peptide on all-cause mortality in heart failure patients with preserved ejection fraction].
Cao J; Jin XJ; Zhou J; Chen ZY; Xu DL; Yang XC; Dong W; Li LW; Luo J; Chen L; Fu M; Zhou JM; Ge JB
Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Nov; 47(11):875-881. PubMed ID: 31744276
[No Abstract] [Full Text] [Related]
17. CT-IGFBP-4 as a novel prognostic biomarker in acute heart failure.
Konev AA; Kharitonov AV; Rozov FN; Altshuler EP; Serebryanaya DV; Lassus J; Harjola VP; Katrukha AG; Postnikov AB
ESC Heart Fail; 2020 Apr; 7(2):434-444. PubMed ID: 31967738
[TBL] [Abstract][Full Text] [Related]
18. Limited value of NT-proBNP as a prognostic marker of all-cause mortality in patients with heart failure with preserved and mid-range ejection fraction in primary care: A report from the swedish heart failure register.
Eriksson B; Wändell P; Dahlström U; Näsman P; Lund LH; Edner M
Scand J Prim Health Care; 2019 Dec; 37(4):434-443. PubMed ID: 31724475
[No Abstract] [Full Text] [Related]
19. The prognostic value of the plasma N-terminal pro-brain natriuretic peptide level on all-cause death and major cardiovascular events in a community-based population.
Zhu Q; Xiao W; Bai Y; Ye P; Luo L; Gao P; Wu H; Bai J
Clin Interv Aging; 2016; 11():245-53. PubMed ID: 27013868
[TBL] [Abstract][Full Text] [Related]
20. NT-proBNP is increased in differentiated thyroid carcinoma patients and may predict cardiovascular risk.
Klein Hesselink EN; van der Horst-Schrivers ANA; van der Horst ICC; Bakker SJL; Muller Kobold AC; Brouwers AH; de Bock GH; Gietema JA; Dullaart RPF; Links TP; Lefrandt JD
Clin Biochem; 2017 Aug; 50(12):696-702. PubMed ID: 28242284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
